What Is a 510(k) Submission and Do You Need One?

Introduction

If you are planning to bring a medical device to the United States market, you have likely come across the term 510(k). It is one of the most common regulatory pathways for medical devices in the US — but it is also one of the most misunderstood.

Many device manufacturers assume that if their product is safe and effective, FDA approval is straightforward. In reality, the US regulatory system has multiple pathways depending on your device type, risk level, and whether a similar device already exists on the market. Choosing the wrong pathway — or not knowing which one applies to you — can cost your team months of rework and thousands of dollars in avoidable delays.

This article explains what a 510(k) submission is, when you need one, when you don't, and how to determine which pathway is right for your device.

What Is a 510(k)?

A 510(k) is a premarket submission made to the FDA to demonstrate that your device is substantially equivalent to a legally marketed device that is already on the US market — known as a predicate device. The name comes from Section 510(k) of the Federal Food, Drug, and Cosmetic Act.

The key concept is substantial equivalence. Your device does not need to be identical to the predicate — it needs to have the same intended use and either the same technological characteristics, or different technological characteristics that do not raise new questions of safety and effectiveness.

If FDA agrees that your device is substantially equivalent, it issues a clearance letter — commonly called 510(k) clearance. This is not the same as FDA approval, which is a separate and more rigorous process used for high-risk devices. Clearance means FDA has determined your device is as safe and effective as the predicate, not that it has independently verified its safety and effectiveness through clinical trials.

Who Regulates Medical Devices in the US?

Medical devices in the United States are regulated by the FDA — specifically by the Center for Devices and Radiological Health, known as CDRH. CDRH oversees the classification of devices, the premarket review process, post-market surveillance, and manufacturing quality requirements under 21 CFR Part 820.

The legal framework is established by the Federal Food, Drug, and Cosmetic Act, with device-specific regulations found primarily in Title 21 of the Code of Federal Regulations, Parts 800 through 898.

FDA Device Classification — The Starting Point

Before you can determine whether you need a 510(k), you need to know your device classification. FDA classifies medical devices into three classes based on risk.

Class I devices are considered low risk and are subject to General Controls only. Most Class I devices are exempt from 510(k) requirements — meaning you can bring them to market without a premarket submission. Examples include bandages, tongue depressors, and manual stethoscopes.

Class II devices carry moderate risk and are subject to General Controls and Special Controls. Most Class II devices require a 510(k) submission before they can be legally marketed in the US. This is the most common category for 510(k) submissions. Examples include infusion pumps, surgical robots, diagnostic ultrasound systems, and powered wheelchairs.

Class III devices are the highest risk — typically life-sustaining or implantable devices. They require Premarket Approval, known as PMA, which is a separate and significantly more rigorous pathway than 510(k). Examples include pacemakers, cochlear implants, and ventricular assist devices.

To find your device classification, use FDA's Product Classification database at accessdata.fda.gov. Search by device name or keyword to find your device type, its associated product code, and its classification.

Do You Need a 510(k)?

Not every device requires a 510(k). Whether you need one depends on your device class and several additional factors.

You generally do not need a 510(k) if your device is Class I and listed as 510(k) exempt in FDA's regulations. You also do not need one if your device was legally marketed in the US before May 28, 1976 — known as a pre-amendments device — and has not been significantly changed since then.

You generally do need a 510(k) if your device is Class II and not specifically exempted, if your device is Class I but has been significantly changed or modified from a previously cleared version, or if you are introducing a device into US commerce for the first time and it falls under a non-exempt classification.

The safest approach is always to confirm your classification and exemption status directly in FDA's regulations and product classification database rather than relying on assumptions or competitor classifications.

The Four 510(k) Pathways

If you determine that a 510(k) is required, the next decision is which type of 510(k) to submit. There are four pathways, each with different requirements and review timelines.

The Traditional 510(k) is the standard pathway and the most commonly used. It requires a full demonstration of substantial equivalence, including device description, intended use comparison, technological characteristics comparison, performance testing data, biocompatibility data, labelling, and a substantial equivalence discussion. FDA's review clock for a Traditional 510(k) is 90 days, though real-world timelines are often longer when FDA issues Additional Information requests.

The Abbreviated 510(k) allows manufacturers to rely on FDA-recognized consensus standards to demonstrate substantial equivalence, reducing the amount of performance data required in the submission. Instead of submitting full test data, you submit a Declaration of Conformity to the applicable standard. This pathway works well when recognized standards fully address your device's performance requirements. The review clock is also 90 days.

The Special 510(k) is available only for modifications to your own legally cleared device. It is limited to design changes that do not affect the intended use or alter the fundamental scientific technology of the device. The key advantage is a significantly shorter review clock — 30 days — making it the fastest 510(k) pathway available. It is not available for new devices or for modifications to another manufacturer's device.

The De Novo request is technically a separate pathway rather than a 510(k), but it is closely related. It is used for novel low-to-moderate risk devices that have no valid predicate on the market. A successful De Novo request results in a new device classification that can then serve as a predicate for future 510(k) submissions. The review clock is 150 days.

What Is Substantial Equivalence?

Substantial equivalence is the central concept in the 510(k) process and is worth understanding clearly before you begin your submission.

A device is substantially equivalent to a predicate if it has the same intended use as the predicate and either the same technological characteristics, or different technological characteristics that do not raise new questions of safety and effectiveness and the device is at least as safe and effective as the predicate.

Intended use refers to the general purpose of the device — what it is intended to do and for whom. Technological characteristics refer to the design, materials, chemical composition, energy source, and other device-specific features.

If your device has the same intended use as the predicate but different technological characteristics, you must demonstrate that those differences do not raise new safety or effectiveness questions. This is typically done through performance testing, biocompatibility data, or other technical evidence included in the submission.

The predicate device must be a legally marketed device — meaning it was either cleared through a previous 510(k), classified as pre-amendments, or granted De Novo classification. You cannot use a device that was recalled, withdrawn, or subject to a Not Substantially Equivalent determination as your predicate.

What Goes Into a 510(k) Submission?

A Traditional 510(k) submission typically includes the following sections, as defined by 21 CFR 807.87 and FDA guidance documents.

Administrative information includes the applicant name and address, device name, establishment registration number, and a signed Truthful and Accurate Statement certifying the submission is complete and accurate.

The device description provides a complete narrative of the device — its mechanism of action, components, materials, dimensions, and principles of operation — along with photographs, engineering drawings, and a list of all configurations and accessories.

The substantial equivalence comparison is the heart of the submission. It documents the predicate device, compares intended use and technological characteristics side by side, and presents a formal substantial equivalence discussion and conclusion.

Proposed labelling includes draft labels and Instructions for Use compliant with 21 CFR Part 801, along with any required warnings, contraindications, and reprocessing instructions if the device is reusable.

Performance testing documents all bench tests, biocompatibility evaluations, electrical safety and EMC testing, software validation, sterility testing, and shelf life studies relevant to your device type.

Software documentation is required for devices that contain software, covering the software level of concern, software description, verification and validation summary, and cybersecurity documentation for connected devices.

Administrative forms include FDA Form 3514 (User Fee Cover Sheet), FDA Form 3881 (Indications for Use), user fee payment confirmation, and a cover letter addressed to the FDA Document Mail Center.

How Long Does the Process Take?

The FDA review clock for a Traditional 510(k) is 90 days from the date FDA accepts the submission. However, this does not mean clearance in 90 days.

Before the clock starts, FDA conducts an Acceptance Review — a 15-day administrative check to confirm the submission is complete. If your submission fails the Acceptance Review, it is placed on hold until deficiencies are corrected.

During review, FDA may issue an Additional Information request asking for clarification or additional data. This stops the FDA clock until you respond, which can add weeks or months to the total timeline.

Realistically, from kick-off to clearance, most Traditional 510(k) submissions take between 12 and 24 months when you account for preparation time, testing, and the FDA review and response cycle.

Common Mistakes to Avoid

The most frequent mistake is selecting the wrong predicate device. Your predicate must be legally marketed, substantially similar in intended use, and ideally recent enough that the technological comparison is straightforward. Using an outdated or poorly matched predicate is one of the most common reasons FDA issues Not Substantially Equivalent determinations.

Submitting an incomplete package is another common error. Missing forms, unsigned statements, or absent test data trigger Acceptance Review failures that delay the clock from even starting.

Underestimating the testing timeline is also widespread. Biocompatibility testing alone can take 8 to 16 weeks. Electrical safety and EMC testing adds another 6 to 12 weeks. Starting testing late in the project is one of the most avoidable causes of submission delays.

Finally, not engaging FDA early for novel devices is a missed opportunity. FDA's Q-Submission program allows manufacturers to request feedback from FDA before submitting — including on predicate selection, testing requirements, and submission strategy. For devices with any novel elements, a Pre-Submission meeting can save significant time and reduce the risk of a Not Substantially Equivalent determination.

Where to Go From Here

If you have confirmed that your device requires a 510(k) and you are ready to start building your submission, the next step is developing a structured project plan that covers predicate selection, testing, documentation, and submission compilation.

Our FDA 510(k) Submission Guide includes an 8-sheet structured workbook covering device classification and pathway selection, a 58-item submission checklist based on 21 CFR 807.87, a predicate device substantial equivalence comparison table, a performance testing matrix with applicable standards and acceptance criteria, a 7-phase timeline planner with realistic duration estimates, and a live submission readiness dashboard.

Get the FDA 510(k) Submission Guide in our shop.